Since 2007 PCFA has administered one of the largest prostate cancer research funding programs in Australia. Our decade-long partnership with The Movember Foundation has led to the establishment of numerous prostate cancer research centres nationally. A new strategy guides our research program from 2015 to 2018, aiming to build on our past success. We fund projects that translate basic research outcomes into new initiatives and therapies, with the goal of reducing the impact of prostate cancer on our community.
Our Research Mission
To make discoveries that will reduce the impact of prostate cancer on Australian men, their partners and families, recognising the diversity of the Australian community.
Our Research Strategy
From 2015 to 2018 our program will focus on consumer priorities such as survivorship and clinical trials. The three pillars of research funding ensure that PCFA continues to support basic science, whilst at the same time embracing consumer priorities such as clinical trials and psychosocial research.
All three pillars sit under the umbrella of the Research Advisory Committee that advises the National Board.
Pillar 1 Basic Science
- Team awards fund translational research teams that are capable of providing the expertise for a near-term, revolutionary and transformative impact on the clinical management of prostate cancer.
- Young Investigator awards Support young promising scientists in their journey to establish their own independent career in prostate cancer research.
- New concept grants fund innovative research ideas that could provide breakthroughs in the field, from prevention to treatment and survivorship. New concepts can be ambitious but must be feasible.
Pillar 2 Clinical Science
- Clinical Trial Awards support clinical trials initiated in Australia that have the capacity to transform the clinical management of prostate cancer patients within the course of the trial and/or immediately after completion of the trial.
- Clinician Scientist Awards support outstanding clinicians who have gained a PhD in health research, to continue their clinical career and establish themselves as researchers in the field of prostate cancer
- Clinical Guidelines fund supports the establishment of three evidence-based clinical guidelines for PSA testing, localised and advanced prostate cancer.
Pillar 3 Survivorship Research
With the increase in prostate cancer survival rates over the last decade, survivorship and quality of life issues related to treatment for prostate cancer have become increasingly important. Funding is available for psychosocial and survivorship research into unmet needs of men with prostate cancer, their partners and families.
Knowledge translation is a process of development and dissemination of research evidence for those who need it. It involves taking new research findings to those who will use them, in an appropriate format. Research proposals need to have a knowledge translation plan that includes:
- Integrated knowledge translation, which requires that knowledge users be members of the research team and participate in many stages of the research process. A specific plan on how to raise awareness amongst potential applicants and how to implement an integrated knowledge translation plan is being drafted by the research office at PCFA.
- End-of-grant knowledge translation, which requires applicants to submit a plan for how they will translate their findings when the research is completed. Similarly, specific guidelines are being drafted to guide expert reviewers through the assessment process of these knowledge translation plans.
In addition, the applicants are required to articulate their knowledge sharing plan to demonstrate that the results achieved are relevant and useful to end users.